Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Generic Pharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:FUM
- CUSIP: N/A
- Web: www.futuramedical.com/
- Market Cap: £32.11 million
- Outstanding Shares: 120,603,000
- 50 Day Moving Avg: GBX 40.30
- 200 Day Moving Avg: GBX 50.29
- 52 Week Range: GBX 28 - GBX 74.80
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $466,019.00
- Price / Sales: 68.90
- Book Value: GBX 0.09 per share
- Price / Book: 2.83
- EBIDTA: ($4,290,000.00)
- Net Margins: -1,745.55%
- Return on Equity: -46.36%
- Return on Assets: -42.12%
- Average Volume: 185,605 shs.
Frequently Asked Questions for Futura Medical plc. (LON:FUM)
What is Futura Medical plc.'s stock symbol?
Futura Medical plc. trades on the London Stock Exchange (LON) under the ticker symbol "FUM."
Who are some of Futura Medical plc.'s key competitors?
Some companies that are related to Futura Medical plc. include Motif Bio PLC (MTFB), Electromed (ELMD), ReNeuron Group Plc (RENE), OptiBiotix Health PLC (OPTI), Bioquell plc (BQE), Capricor Therapeutics (CAPR), Avacta Group Plc (AVCT), Actinium Pharmaceuticals (ATNM), Abzena PLC (ABZA), Amryt Pharma PLC (AMYT), Invivo Therapeutics Holdings Corp (NVIV), Ampio Pharmaceuticals (AMPE), Midatech Pharma PLC (MTPH), Redx Pharma PLC (REDX), Oncobiologics (ONS), Scancell Holdings Plc (SCLP), Cambridge Cognition Holdings PLC (COG) and Can Fite Biopharma Ltd (CANF).
Who are Futura Medical plc.'s key executives?
Futura Medical plc.'s management team includes the folowing people:
- James Henry Barder, Chief Executive Officer, Executive Director
- Derek Adrian Martin, Finance Director, Company Secretary, Executive Director
- Ken James, Executive Director, Head of R&D
- John Milne Clarke, Non-Executive Chairman of the Board
- Lisa Arnold, Independent Non-Executive Director
- Jonathan David Freeman, Senior Independent Non-Executive Director
How do I buy Futura Medical plc. stock?
Shares of Futura Medical plc. and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Futura Medical plc.'s stock price today?
MarketBeat Community Rating for Futura Medical plc. (LON FUM)MarketBeat's community ratings are surveys of what our community members think about Futura Medical plc. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Futura Medical plc. stock can currently be purchased for approximately GBX 26.63.
Consensus Ratings for Futura Medical plc. (LON:FUM) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Futura Medical plc. (LON:FUM)
(Data available from 9/24/2015 forward)
|9/22/2017||N+1 Singer||Reiterated Rating||corporate|
Earnings History for Futura Medical plc. (LON:FUM)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Futura Medical plc. (LON:FUM)
Current Year EPS Consensus Estimate: $-5.500 EPS
Dividend History for Futura Medical plc. (LON:FUM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Futura Medical plc. (LON:FUM)Insider Trades by Quarter for Futura Medical plc. (LON:FUM)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|1/12/2017||James Henry Barder||Insider||Sell||210,000||GBX 55||£115,500|
|1/10/2017||Jonathan David Freeman||Insider||Buy||35,803||GBX 57||£20,407.71|
|1/5/2015||John M Clarke||Insider||Buy||23,431||GBX 63.25||£14,820.11|
Headline Trends for Futura Medical plc. (LON:FUM)
Latest Headlines for Futura Medical plc. (LON:FUM)
Futura Medical plc. (FUM) Chart for Sunday, September, 24, 2017